Liu X - Search Results

1

Study on the mechanism of Danshen-Guizhi drug pair in the treatment of ovarian cancer based on network pharmacology and in vitro experiment.

Qin C, Wu M, Wang X, Zhang W, Qi G, Wu NY, Liu X, Lu Y, Zhang J, Chai Y. Qin C, et al. Among authors: liu x. PeerJ. 2022 Apr 6;10:e13148. doi: 10.7717/peerj.13148. eCollection 2022. PeerJ. 2022. PMID: 35411258 Free PMC article.

2

ZNF582 promoter methylation predicts cervical cancer radiosensitivity and ZNF582 protein overexpression reduces radiosensitivity by cell cycle arrest in S phase.

Wu N, Zhang X, Zhu M, Fang C, Liu X, Wang Y, Li H, Liu S, Ting H, Qin C, Liao Q, Cai J, Wang J. Wu N, et al. Among authors: liu x, liu s. Epigenetics. 2022 Dec;17(12):1786-1799. doi: 10.1080/15592294.2022.2080995. Epub 2022 Jun 9. Epigenetics. 2022. PMID: 35642528 Free PMC article.

3

Studying the mechanism underlying lipid metabolism in osteosarcoma based on transcriptomic RNA sequencing and single-cell data.

Li Z, Jin C, Lu X, Zhang Y, Zhang Y, Wen J, Liu Y, Liu X, Li J. Li Z, et al. Among authors: liu y, liu x. J Gene Med. 2023 Jun;25(6):e3491. doi: 10.1002/jgm.3491. Epub 2023 Mar 13. J Gene Med. 2023. PMID: 36847293

4

Somatic mutation profiling, tumor-infiltrating leukocytes, tertiary lymphoid structures and PD-L1 protein expression in HER2-amplified colorectal cancer.

Liu XT, Kou ZY, Zhang H, Dong J, Zhang JH, Peng YJ, Ma SM, Liang L, Meng XY, Zhou Y, Yang J. Liu XT, et al. PeerJ. 2023 May 2;11:e15261. doi: 10.7717/peerj.15261. eCollection 2023. PeerJ. 2023. PMID: 37151285 Free PMC article.

5

Circular RNA circ-PLCD1 functions as a tumor suppressor in non-small cell lung cancer by inactivation of PI3K/AKT signaling pathway.

Si J, Jin J, Sai J, Liu X, Luo X, Fu Z, Wang J. Si J, et al. Among authors: liu x. Hum Cell. 2022 May;35(3):924-935. doi: 10.1007/s13577-022-00691-8. Epub 2022 Mar 17. Hum Cell. 2022. PMID: 35301686

6

Identification of thioredoxin-1 as a biomarker of lung cancer and evaluation of its prognostic value based on bioinformatics analysis.

Liu X, Dong X, Hu Y, Fang Y. Liu X, et al. Front Oncol. 2023 Jan 27;13:1080237. doi: 10.3389/fonc.2023.1080237. eCollection 2023. Front Oncol. 2023. PMID: 36776308 Free PMC article.

7

Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma.

Li Z, Jin C, Lu X, Zhang Y, Zhang Y, Wen J, Liu Y, Liu X, Li J. Li Z, et al. Among authors: liu y, liu x. Ann Transl Med. 2023 Jan 31;11(2):61. doi: 10.21037/atm-22-6011. Ann Transl Med. 2023. PMID: 36819514 Free PMC article.

8

Developing a 5-Gene Signature Related to Pyroptosis for Osteosarcoma Patients.

Li Z, Jin C, Lu X, Zhang Y, Zhang Y, Wen J, Liu Y, Liu X, Li J. Li Z, et al. Among authors: liu y, liu x. J Oncol. 2022 Aug 5;2022:1317990. doi: 10.1155/2022/1317990. eCollection 2022. J Oncol. 2022. PMID: 36035315 Free PMC article.

9

Engineering cancer cell membrane-camouflaged metal complex for efficient targeting therapy of breast cancer.

Li X, Yu Y, Chen Q, Lin J, Zhu X, Liu X, He L, Chen T, He W. Li X, et al. Among authors: liu x. J Nanobiotechnology. 2022 Sep 5;20(1):401. doi: 10.1186/s12951-022-01593-5. J Nanobiotechnology. 2022. PMID: 36064356 Free PMC article.

10

Clinical Application of Sacubitril/Valsartan in Heart Failure.

Liu X, Zhong L. Liu X, et al. Am J Ther. 2021 Apr 8;28(4):e511-e513. doi: 10.1097/MJT.0000000000001340. Am J Ther. 2021. PMID: 33852477 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,382 results

Search Page

Filters